Connect with us

Health

Prior MMR or Tdap vaccination may reduce risk of severe COVID-19 – News-Medical.Net

Researchers in the United States have shown that prior Measles-Mumps-Rubella (MMR) or Tetanus-Diphtheria-pertussis (Tdap) vaccination may reduce the risk of severe…

Published

on

Article feature image

Researchers in the United States have shown that prior Measles-Mumps-Rubella (MMR) or Tetanus-Diphtheria-pertussis (Tdap) vaccination may reduce the risk of severe outcomes in patients with coronavirus disease 2019 (COVID-19).
The team provided evidence that infection with the COVID-19 causative agent – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – reactivates memory T cells previously generated by MMR and Tdap vaccination and that this may reduce the severity of COVID-19.
“Our…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Researchers develop new therapeutic approach for treating acute myeloid leukemia – News-Medical.Net
Article feature image
New tool exposes deeply entrenched inequities in COVID-19 outcomes – News-Medical.Net